SBI Healthcare Opportunities Fund · Regular · Growth
NAV
₹505.9062
as of 30 Sept 2026
Expense Ratio
1.99%
AUM
₹4,489 Cr
Lumpsum returns (CAGR)
- 1Y
- +20.41%
- 3Y
- +21.69%
- 5Y
- +16.62%
- Since Inception
- +15.49%
SIP returns (XIRR)
- 1Y
- +24.12%
- 3Y
- +17.69%
- 5Y
- +20.59%
- Since Inception
- +16.31%
What history actually did — last 10 years (Oct 2016 – Sept 2026)
A ₹5,000 monthly SIP for the last 10 years (Oct 2016 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹15,98,035 today — ₹5,95,000 invested, 19.0% XIRR.
₹5,95,000
Invested
₹15,98,035
Value today
19.0%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Oct 2016 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,46,702 today (13.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Oct 2016 would still hold ₹18,68,985.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹15,98,035 in this fund vs ₹11,23,105 in the benchmark — outperformance of ₹4,74,930.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Oct 2016 – Sept 2026) (22 Mar 2020) would be ₹4,92,218 today (4.92×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.70
Sharpe Ratio
+0.13
Alpha
0.14
Beta
0.70
Sortino
11.96%
Std Dev
-9.63%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology62.04%
- Healthcare Services27.64%
- Chemicals & Petrochemicals5.17%
- Healthcare Equipment & Supplies1.94%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about SBI Healthcare Opportunities Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.12.33%
- 2Divi'S Laboratories Ltd.8.17%
- 3Apollo Hospitals Enterprise Ltd.4.91%
- 4Acutaas Chemicals Ltd.4.91%
- 5Torrent Pharmaceuticals Ltd.4.72%
- 6Cipla Ltd.4.67%
- 7Max Healthcare Institute Ltd.4.31%
- 8Laurus Labs Ltd.3.96%
- 9Aurobindo Pharma Ltd.3.90%
- 10Aster Dm Quality Care Ltd.3.52%
What this fund does
SBI Healthcare Opportunities Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 27 years. It manages assets worth ₹4,489 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TRI. The current expense ratio is 1.99%.